Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Blincyto
Pharma
Amgen's Blincyto proves its worth in pediatric leukemia study
The drug, along with chemotherapy, kept 96% of B-cell acute lymphoblastic leukemia patients alive and disease-free at the three-year mark.
Zoey Becker
Dec 9, 2024 11:43am
Improved access helps Amgen's Tepezza to a sales increase
Aug 7, 2024 8:35am
FDA approves Amgen's potential lung cancer blockbuster Imdelltra
May 17, 2024 12:12pm
Amgen reports 3rd straight sequential sales increase for Tepezza
Feb 7, 2024 10:03am
ASH: Amgen's Blincyto looks to establish new leukemia standard
Dec 13, 2022 10:00am
Amgen links Chicago artists, social media voices in ASCO push
Jun 11, 2019 9:59am
